21423. ¿ES LA ALODINIA CUTÁNEA UN PREDICTOR DE BUENA RESPUESTA EN PACIENTES CON MIGRAÑA EN TRATAMIENTO CON ANTI-CGRP? by Antón Conejos, Á., Arcila Salazar, D., Cheli García, D., Almeida Zurita, P., Cajape Mosquera, J., del Moral Sahuquillo, B., Noroña Vásconez, E., Garcés Becerril, E., Ginarte Milanés, D., Santos Lasaosa, S.

Get full text

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study by Kosiborod, Mikhail, Lam, Carolyn S P, Kohsaka, Shun, Kim, Dae Jung, Karasik, Avraham, Shaw, Jonathan, Tangri, Navdeep, Goh, Su-Yen, Thuresson, Marcus, Chen, Hungta, Surmont, Filip, Hammar, Niklas, Fenici, Peter

Get full text

Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data by Khunti, Kamlesh, Kosiborod, Mikhail, Kim, Dae Jung, Kohsaka, Shun, Lam, Carolyn S P, Goh, Su-Yen, Chiang, Chern-En, Shaw, Jonathan E, Cavender, Matthew A, Tangri, Navdeep, Franch-Nadal, Josep, Holl, Reinhard W, Jørgensen, Marit E, Norhammar, Anna, Eriksson, Johan G, Zaccardi, Francesco, Karasik, Avraham, Magliano, Dianna J, Thuresson, Marcus, Chen, Hungta, Wittbrodt, Eric, Bodegård, Johan, Surmont, Filip, Fenici, Peter

Get full text